XM does not provide services to residents of the United States of America.
G
G

Galapagos

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

U.S. Elf Beauty, Moderna, Zscaler

U.S. RESEARCH ROUNDUP-Elf Beauty, Moderna, Zscaler Feb 26 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Elf Beauty, Moderna, and Zscaler, on Monday. HIGHLIGHTS * Elf Beauty Inc ELF.N : Piper Sandler raises target price to $225 from $212 * Elevance Health Inc ELV.N : JP Morgan raises target price to $560 from $552 * Moderna MRNA.O : HSBC cuts to reduce from hold * Molina Healthcare Inc MOH.N : JP Morgan raises target
A
B
B
B
G
L
D
H
C
D

Allianz SE, Halma, ITM Power

EUROPE RESEARCH ROUNDUP-Allianz SE, Halma, ITM Power Feb 26 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Allianz SE, Halma and ITM Power Plc on Monday. HIGHLIGHTS * Allianz SE ALVG.DE : JP Morgan raises target price to EUR 275 from EUR 270 * Halma HLMA.L : HSBC cuts to hold from buy * ITM Power Plc ITM.L : Jefferies raises to buy from hold * Nel ASA NEL.OL : Jefferies cuts to hold from buy * Orion Oyj ORNBV.HE : Jefferies cuts t
A
A
B
B
B
B
B
C
C
D
E
E
E
F
G
G
G
H
L
R
S
S
T
A
A
A
A
A
A
B

Galapagos NV reports results for the quarter ended in December - Earnings Summary

Galapagos NV reports results for the quarter ended in December - Earnings Summary Galapagos NV GLPG.AS reported quarterly adjusted earnings of €2.39​​ per share for the quarter ended in December, higher than the same quarter last year, when the company reported EPS of €-3.16. The mean expectation of four analysts for the quarter was for a loss of €3.93 per share.
G

Galapagos NV <GLPG.OQ> expected to post a loss of €1.18 a share - Earnings Preview

Galapagos NV expected to post a loss of €1.18 a share - Earnings Preview Galapagos NV GLPG.OQ , GLPG.O is expected to show a rise in quarterly revenue when it reports results on February 22 for the period ending December 31 2023 The Malines (mechelen) Antwerpen-based company is expected to report a 3.4% increase in revenue to €98.324 million from €95.12 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.
G

Galapagos NV <GLPG.AS> expected to post a loss of €3.93 a share - Earnings Preview

Galapagos NV expected to post a loss of €3.93 a share - Earnings Preview Galapagos NV GLPG.AS is expected to show a fall in quarterly revenue when it reports results on February 22 for the period ending December 31 2023 The Malines (mechelen) Antwerpen-based company is expected to report a 14.3% decrease in revenue to €81.505 million from €95.12 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.
G

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.